A detailed history of Concurrent Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 19,645 shares of AMGN stock, worth $5.79 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
19,645
Previous 17,773 10.53%
Holding current value
$5.79 Million
Previous $5.55 Billion 13.99%
% of portfolio
0.19%
Previous 0.18%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$309.38 - $337.38 $579,159 - $631,575
1,872 Added 10.53%
19,645 $6.33 Billion
Q2 2024

Jul 30, 2024

BUY
$262.75 - $319.31 $794,293 - $965,274
3,023 Added 20.49%
17,773 $5.55 Billion
Q1 2024

May 07, 2024

BUY
$268.87 - $324.56 $165,623 - $199,928
616 Added 4.36%
14,750 $4.19 Billion
Q4 2023

Apr 15, 2024

BUY
$255.7 - $288.46 $3.61 Million - $4.08 Million
14,134 New
14,134 $4.07 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Concurrent Investment Advisors, LLC Portfolio

Follow Concurrent Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concurrent Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Concurrent Investment Advisors, LLC with notifications on news.